The PharmaMar Foundation is proud to have successfully concluded the first edition of our awards, where we were honored to recognize and reward professionals and projects that have made a significant difference in the field of scientific research and healthcare. Each award given reflects our ongoing commitment to advancing medicine and improving patient care, as well as our unwavering support for innovation and excellence in research.

We invite you to learn about this year’s awardees and the details of their outstanding contributions in the various categories, which demonstrate the transformative impact of their work on our society.

Argonauta Awards Winners 2023

Award for the
Best Clinical Case Report

The PharmaMar Foundation has awarded Dr. Gros for his innovative work in the treatment of advanced and refractory peritoneal mesothelioma, conducted in collaboration with Dr. Antonia Digklia and titled "Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases".

Award for Best Care Provision
to Hospitalized Covid Patients

The PharmaMar Foundation has awarded Dr. Pedro Landete for his commendable work in treating hospitalized COVID-19 patients.

Lifetime Achievement Award
in Basic Research

Adolfo García-Sastre is deserving of the Lifetime Achievement Award in Basic Research for his exceptional career in the field of virology and immunology, standing out for his innovations in vaccine development and his crucial contribution to the understanding and combat of viral pathogens such as influenza, SARS-CoV-2, and other viruses of importance in human health.

Lifetime Achievement Award
in Clinical Research

The Foundation presents the Lifetime Achievement Award in Clinical Research to Dr. Josep Tabernero for his distinguished career in clinical research and medical oncology, acknowledging his leadership in the development of molecular therapies against cancer and his significant contributions to translational medicine, as reflected in his extensive scientific work and his global impact on the oncological community.